During the past decade, Heart Hospital, Hamad Medical Coorporation conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Heart Hospital, Hamad Medical Coorporation" are "Atrial Fibrillation" (1 trials), "CVD" (1 trials), "Myocardial Infarction" (1 trials), "PreDiabetes" (1 trials) and "Risk Reduction" (1 trials). Many other conditions were trialed in "Heart Hospital, Hamad Medical Coorporation" in a lesser frequency.

Most popular intervention types in "Heart Hospital, Hamad Medical Coorporation" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dapagliflozin 10mg" (1 trials), "Pioglitazone Plus dapaglifliozin" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heart Hospital, Hamad Medical Coorporation" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Heart Hospital, Hamad Medical Coorporation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Heart Hospital, Hamad Medical Coorporation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Heart Hospital, Hamad Medical Coorporation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".